Your institution may have access to this item. Find your institution then sign in to continue.
Title
From the FDA.
Abstract
The article reports on several drugs approved by the U.S. Food and Drug Administration. The agency has given final approval for bupropion extended release tablets manufactured by Biovail Laboratories International. Solvay Pharmaceuticals Inc.s' extended release fluvoxamine has been approved for treating social anxiety disorder and obsessive-compulsive in adults.